Archive: 09/06/2021

Study examines COVID-19 among patients receiving home dialysis

Individuals with kidney failure who receive dialysis treatments in clinics (called in-center dialysis) are especially vulnerable to COVID-19, with death rates reported at over 20% in recent studies; however, there has been ...

Jun 9, 2021

0

3

New treatment demonstrated for people with vaccine clots

A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by scientists at McMaster University.

Jun 9, 2021

0

12

Immune responses after COVID-19 vaccination in kidney transplant and dialysis patients

A new study reveals the extent to which kidney transplant recipients and individuals with kidney failure who are on dialysis mount immune responses—which include the production of antibodies and the activation of T cells—to ...

Jun 9, 2021

0

3

Creating a needle-free COVID-19 vaccine

Vaccines are mostly synonymous with needles, an efficient and effective way to provide immunity to myriad infections. As COVID-19 vaccination efforts roll out across the U.S. and the world, some experts believe that a vaccine ...

Jun 9, 2021

0

1

Newborns on ventilators can now be better protected from a common breathing tube incident

If a newborn is moved or becomes agitated while on a ventilator, the breathing tube also could move. Just a few seconds with the tube in the wrong position might lead to a critical lack of oxygen to the brain, possibly resulting ...

Jun 9, 2021

0

4

Understanding gut inflammation may hold clues to mitigating Parkinson's onset

Chronic inflammation in the gut may propel processes in the body that give rise to Parkinson's disease, according to a study by scientists at Van Andel Institute and Roche.

Jun 9, 2021

Disparities in treatment persist for people with headache

Disparities exist in the treatment of people with headache disorders because of race and ethnicity, socioeconomic status and geography, according to a review article published in the June 9, 2021, online issue of Neurology.

Jun 9, 2021

0

0

There's a new Alzheimer's drug, so what's the problem? A doctor explains.

After years of disappointing studies of potential treatments for the more than 6 million people living with Alzheimer's disease, the U.S. Food and Drug Administration recently approved a new drug called aducanumab that is ...

Jun 9, 2021

0

3

Fully vaccinated Canadians can avoid border quarantine soon

Canada's health minister said Wednesday that fully vaccinated Canadian citizens who test negative for COVID-19 will soon be exempt from two weeks quarantine when returning to the country.

Jun 9, 2021

0

4

US 'to buy 500 mn doses for world' as curbs ease in Europe

The United States is set to buy 500 million COVID-19 vaccine doses to distribute around the world, media reported Wednesday, as France and Belgium relaxed virus restrictions to allow restaurants and cafes to serve indoors.

Jun 9, 2021

0

0

page 1 from 11

«
»